TransMedics Group, Inc. Operating Lease, Liability, Current
TransMedics Group, Inc. (TMDX) had Operating Lease, Liability, Current of $3.65 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-04
- 2026-06-30: Operating Lease, Liability, Current $3.65M.
- 2026-03-31: Operating Lease, Liability, Current $3.51M.
- 2025-12-31: Operating Lease, Liability, Current $3.31M.
- 2025-09-30: Operating Lease, Liability, Current $3.24M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $3.65M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $3.51M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $3.31M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $3.24M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $3.02M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $2.79M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.73M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.54M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $2.14M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $2.09M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $2.04M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.99M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.88M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $1.48M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.44M 10-K · filed 2024-02-27 |
| 2022-09-30 | $1.41M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.37M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $1.34M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |